Standard edition guidance for targeted drug use in cancer
Standard edition guidance for targeted drug use in cancer
- Standard tumors 52 genetic testing is based on the multiple PCR technology and Ion Torrent semiconductor sequencing platform, disposable detection of EGFR, KRAS, NRAS, mutated BRAF, HER2, KIT and PDGFRA 52 hot solid tumor related genes of more than 2800
